Fortress Biotech, Inc. (FBIO) Deferred Tax Assets, Valuation Allowance USD 2011 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Fortress Biotech, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2011 to 2023.
  • Fortress Biotech, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $366 M, a 15.2% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $366 M +$48.4 M +15.2% Dec 31, 2023 10-K 2024-03-28
Q4 2022 $318 M +$66.9 M +26.7% Dec 31, 2022 10-K 2024-03-28
Q4 2021 $251 M +$47.1 M +23.1% Dec 31, 2021 10-K 2023-03-31
Q4 2020 $204 M +$35.7 M +21.2% Dec 31, 2020 10-K 2022-03-28
Q4 2019 $168 M +$36.1 M +27.3% Dec 31, 2019 10-K/A 2021-04-09
Q4 2018 $132 M +$30.5 M +30% Dec 31, 2018 10-K 2020-03-16
Q4 2017 $102 M +$102 M +107248% Dec 31, 2017 10-K 2019-03-18
Q4 2016 $94.7 K* +$28 K +41.9% Dec 31, 2016 10-K 2018-03-16
Q4 2015 $66.7 K* -$50.5 M -99.9% Dec 31, 2015 10-K 2017-03-16
Q4 2014 $50.6 M +$9.43 M +22.9% Dec 31, 2014 10-K 2016-03-15
Q4 2013 $41.1 M +$41.1 M +156925% Dec 31, 2013 10-K 2015-03-16
Q4 2012 $26.2 K* -$17 M -99.8% Dec 31, 2012 10-K 2014-03-14
Q4 2011 $17 M Dec 31, 2011 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.